March 5 (Reuters) - Eli Lilly and Co and partner Boehringer Ingelheim said U.S. regulators have declined to approve their experimental diabetes drug empagliflozin, citing previously observed problems...
The FDA declines to approve Eli Lilly 's ( LLY -0.5% ) Empagliflozin treatment for Type 2 diabetes ..... the issues need to be resolved before it can OK the application. Eli Lilly doesn't need to carry out further clinical trials. ( PR ) Post
March 5 (Reuters) - Eli Lilly and Co and partner Boehringer Ingelheim said U.S. regulators have declined to approve their experimental diabetes drug empagliflozin, citing previously observed deficiencies at a manufacturing facility where it would be made.
Eli Lilly and Co ( LLY ) Cowen and Company 34th Annual Health Care Conference March 4 ..... Presentation Steve Scala – Cowen & Co. Good morning. I would like to welcome Eli Lilly to Cowen's 34th annual healthcare conference. Representing the company
their quality of life and ability to stay in their own homes. In this article I will be analyzing the differences between Eli Lilly 's ( LLY ) Solanezumab and Prana Biotechnology's ( PRAN ) PBT2 -- the new leading candidates in the Complete Story
marketed respectively under licence by KV Pharmaceuticals, Eli Lilly , and Gedeon Richter. On a combined basis, the contribution ..... limited control over sales given the out-licencing deal to Eli Lilly . Although the testosterone supplementation category has
understanding of Acrux's potential, Eli Lilly may move to acquire the company ..... high-value licensing deal with Eli Lilly . Acrux fully developed Axiron so ..... product applications to Elanco, Eli Lilly 's animal health-care division
TEVA Pharmaceuticals ( TEVA ) gains FDA clearance for generic 60 mg raloxifene tablets. The product competes with Eli Lilly 's Evista (2013 sales of $824M). Teva was the first to file, so it gets 180 days marketing exclusivity. Shipments
91 123,446 5 Du Pont DD 3 High Narrow 66.62 1.11 62,385 4 Vodafn VOD 2 Medium Narrow 41.57 1.15 110,729 3 Eli Lilly LLY 3 Medium Wide 59.61 1.01 66,825 4 Unilever UL 3 Medium Wide 41.03 0.91 124,232 3 eBay EBAY 3 Medium Wide
By Peter Geschek : In February Eli Lilly ( LLY ) announced positive results from the sixth Award trial for the once-weekly experimental drug dulaglutide. Dulaglutide